Scaling up medications for opioid use disorder in residential treatment programs

Who could benefit from this research

What this research studies

Opioid use disorder treatments like methadone, buprenorphine, and naltrexone are proven to reduce overdoses, but their use in residential programs is limited. The project aims to understand and accelerate how these medications can be adopted in residential treatment settings, especially after patients leave custody of these facilities when overdose risk is high. It will analyze large data sets and state policies to identify factors that promote MOUD uptake in RTPs and examine reimbursement changes under CMS policies. The effort combines implementation science with data integration to inform scalable, patient-centered strategies for improving treatment access and continuity of care. This work seeks to build practical knowledge that could help more people with opioid use disorder receive life-saving medications in a setting where they are transitioning back into the community.

Why it matters

Where this research is happening

• Rutgers Biomedical and Health Sciences
  Newark, United States Active

Researchers

• Principal investigator: Miles, Jennifer — Rutgers Biomedical and Health Sciences
• Study coordinator: Miles, Jennifer

Related research

Other NIH-funded projects on the same topics.

• Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)

  A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.

  NIH research University of Washington · Seattle, United States · NIH-11599161

• Precise epigenetic drugs for opioid addiction

  A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.

  NIH research Boston Interactome, INC. · Boston, United States · NIH-11578588

• Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans

  This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.

  NIH research Open Aid Alliance · Missoula, United States · NIH-11578581

• Optimizing long-acting PrEP and opioid treatment for people in jails and prisons

  This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.

  NIH research Duke University · Durham, United States · NIH-11565766

• Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN

  This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.

  NIH research Native American Community Clinic · Minneapolis, United States · NIH-11533803

• Multimodal fetal and placental imaging to predict outcomes in infants exposed to opioids

  This project uses brain and placenta imaging plus biomarkers to understand how prenatal opioid exposure affects babies and how to predict and improve outcomes for infants born to mothers with opioid use disorder.

  NIH research University of Pittsburgh at Pittsburgh · Pittsburgh, United States · NIH-11518816

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.